(Press-News.org) LOS ANGELES (March 15, 2012) - In the past decade, results from large prospective cohort studies and the Women's Health Initiative (WHI) randomized placebo-controlled hormone therapy trials have substantially changed thoughts about how estrogen alone and estrogen plus progestin influence the risk of breast cancer, according to a review published TK in the Journal of The National Cancer Institute.
Although hormone therapy is currently used by millions of women for menopausal symptoms, there is still concern about hormone therapy–induced breast cancer risk. In addition, the effects of estrogen plus progestin versus estrogen alone on breast cancer are not completely understood.
To compare the effects of estrogen alone versus those of estrogen plus progestin on breast cancer risk, Rowan T. Chlebowski, M.D., Ph.D., of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and Garnet Anderson, Ph.D., at Fred Hutchinson Cancer Research Center, looked at data from two randomized, placebo-controlled full scale clinical trials conducted in the WHI. One trial evaluated estrogen plus progestin in postmenopausal women with an intact uterus, and the other evaluated estrogen alone in postmenopausal women with prior hysterectomy. Estrogen plus progestin statistically significantly increased the risk of breast cancer. In contrast, estrogen alone use in postmenopausal women with a previous hysterectomy, statistically significantly decreased the risk of breast cancer.
The randomized clinical trial findings differ from the predominance of observational studies, which suggested that both estrogen alone and estrogen plus progestin increase breast cancer incidence. Dr. Chlebowksi explains that "an imbalance in the use of mammography with greater screening for hormone users could explain some of the increase in breast cancer incidence with estrogen alone seen in cohort studies because screened populations have more cancers detected than unscreened populations."
While the mechanisms underlying the different effects of estrogen alone and estrogen plus progestin are not completely understood, the authors state that preclinical and other clinical evidence suggests "the findings in the clinic, taken together with preclinical evidence, indicate that many breast cancers in post-menopausal women can survive only a limited range of estrogen exposures."
### About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org
Dr. Rowan Chlebowski: Effects of estrogen alone vs. estrogen plus progestin on breast cancer risk
Menopausal hormone therapy and breast cancer risk: Emerging evidence from randomized trials
2012-03-19
ELSE PRESS RELEASES FROM THIS DATE:
Fraser Yachts: Superyachts for Sale This Summer 2012
2012-03-19
Fraser Yachts has a fantastic portfolio of luxury yachts for sale, four of which can be viewed at this year's Antibes Yacht Show (April 12-15th). Fraser Yachts brokers will, of course, be in attendance with M/Y LIVIA, M/Y BEYOND, M/Y VOYAGER and S/Y ALIA 82.
Built in 2009 by the respected Moonen shipyard, the motor yacht LIVIA is a 30m yacht for sale exclusively through Fraser Yachts. Exquisitely appointed throughout she can accommodate up to eight guests and four crew in modern, spacious living quarters. Sail round the Mediterranean this summer at a comfortable 12 ...
Wild orangutans stressed by eco-tourists, but not for long, IU study out of north Borneo finds
2012-03-19
BLOOMINGTON, Ind. -- Wild orangutans that have come into contact with eco-tourists over a period of years show an immediate stress response but no signs of chronic stress, unlike other species in which permanent alterations in stress responses have been documented, new research from an Indiana University anthropologist has found.
IU anthropologist Michael P. Muehlenbein can't say yet what makes the wild orangutans of Borneo deal with stress differently than other species in other locations, but an analysis of orangutan stress hormone levels recorded before, during and ...
Researchers develop graphene supercapacitor holding promise for portable electronics
2012-03-19
Electrochemical capacitors (ECs), also known as supercapacitors or ultracapacitors, differ from regular capacitors that you would find in your TV or computer in that they store substantially higher amounts of charges. They have garnered attention as energy storage devices as they charge and discharge faster than batteries, yet they are still limited by low energy densities, only a fraction of the energy density of batteries. An EC that combines the power performance of capacitors with the high energy density of batteries would represent a significant advance in energy storage ...
A wandering mind reveals mental processes and priorities
2012-03-19
MADISON – Odds are, you're not going to make it all the way through this article without thinking about something else.
In fact, studies have found that our minds are wandering half the time, drifting off to thoughts unrelated to what we're doing – did I remember to turn off the light? What should I have for dinner?
A new study investigating the mental processes underlying a wandering mind reports a role for working memory, a sort of a mental workspace that allows you to juggle multiple thoughts simultaneously.
Imagine you see your neighbor upon arriving home one ...
Process makes polymers truly plastic
2012-03-19
DURHAM, N.C. -- Just as a chameleon changes its color to blend in with its environment, Duke University engineers have demonstrated for the first time that they can alter the texture of plastics on demand, for example, switching back and forth between a rough surface and a smooth one.
By applying specific voltages, the team has also shown that it can achieve this control over large and curved surface areas.
"By changing the voltage applied to the polymer, we can alter the surface from bumpy to smooth and back again," said Xuanhe Zhao, assistant professor of mechanical ...
Combination treatment in mice shows promise for fatal neurological disorder in kids
2012-03-19
Infants with Batten disease, a rare but fatal neurological disorder, appear healthy at birth. But within a few short years, the illness takes a heavy toll, leaving children blind, speechless and paralyzed. Most die by age 5.
There are no effective treatments for the disease, which can also strike older children. And several therapeutic approaches, evaluated in mouse models and in young children, have produced disappointing results.
But now, working in mice with the infantile form of Batten disease, scientists at Washington University School of Medicine in St. Louis ...
Fraser Yachts: Global Charter Options 2012
2012-03-19
Motor yacht IONIAN PRINCESS is a luxury yacht for charter based in Athens and can be chartered in Greece or anywhere on the Mediterranean this summer. Able to accommodate 12 guests in elegant yet comfortable quarters the motor yacht IONIAN PRINCESS is an exceptional vessel to sail upon.
Charter guests can choose to dine in one of three designated areas. One option is the sundeck, complete with barbeque; alternatively the aft deck of the sky lounge offers fantastic views or, for more formal dining there is the main salon. Appointed with only the finest of materials throughout ...
Cancer cells send out the alarm on tumor-killing virus
2012-03-19
COLUMBUS, Ohio – Brain-tumor cells that are infected with a cancer-killing virus release a protein "alarm bell" that warns other tumor cells of the impending infection and enables them to mount a defense against the virus, according to a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The infected tumor cells release a protein called CCN1 into the narrow space between cells where it initiates an antiviral response. The response limits the spread ...
Biomarkers: New tools of modern medicine
2012-03-19
Philadelphia, PA, March 15, 2012 – Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.
In a commentary introducing this single-topic issue, Nikolaos G. Frangogiannis, MD, The Wilf Family Cardiovascular ...
Study looks at discrimination's impact on smoking
2012-03-19
Smoking, the leading preventable cause of mortality in the United States, continues to disproportionately impact lower income members of racial and ethnic minority groups.
In a new study published in the American Journal of Public Health, Jason Q. Purnell, PhD, assistant professor at the Brown School at Washington University in St. Louis, looked at how perceived discrimination influences smoking rates among these groups.
"We found that regardless of race or ethnicity, the odds of current smoking were higher among individuals who perceived that they were treated differently ...
LAST 30 PRESS RELEASES:
Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment
Impact of COVID-19 on education not going away, UM study finds
School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods
Three Speculum articles recognized with prizes
ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology
Incarcerated people are disproportionately impacted by climate change, CU doctors say
ESA 2025 Graduate Student Policy Award Cohort Named
Insomnia, lack of sleep linked to high blood pressure in teens
Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults
Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk
Large study of dietary habits suggests more plant oils, less butter could lead to better health
Butter and plant-based oils intake and mortality
20% of butterflies in the U.S. have disappeared since 2000
Bacterial ‘jumping genes’ can target and control chromosome ends
Scientists identify genes that make humans and Labradors more likely to become obese
Early-life gut microbes may protect against diabetes, research in mice suggests
Study raises the possibility of a country without butterflies
Study reveals obesity gene in dogs that is relevant to human obesity studies
A rapid decline in US butterfly populations
Indigenous farming practices have shaped manioc’s genetic diversity for millennia
Controlling electrons in molecules at ultrafast timescales
Tropical forests in the Americas are struggling to keep pace with climate change
Brain mapping unlocks key Alzheimer’s insights
Clinical trial tests novel stem-cell treatment for Parkinson’s disease
Awareness of rocky mountain spotted fever saves lives
Breakthrough in noninvasive monitoring of molecular processes in deep tissue
BU researcher named rising star in endocrinology
Stressed New Yorkers can now seek care at Mount Sinai’s new resilience-focused medical practice
BU researchers uncover links between metabolism and aggressive breast cancer
Engineers took apart batteries from Tesla and China’s leading EV manufacturer to see what’s inside
[Press-News.org] Dr. Rowan Chlebowski: Effects of estrogen alone vs. estrogen plus progestin on breast cancer riskMenopausal hormone therapy and breast cancer risk: Emerging evidence from randomized trials